CSL Behring - PDFSEARCH.IO - Document Search Engine

CSL Behring
Results: 236

#	Item
11	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites Add to Reading List Source URL: www.cslbehring.at Language: English - Date: 2013-11-18 05:52:29 Blood Coagulation system Haemophilia Medicine Peripheral membrane proteins CSL Behring Recombinant proteins CSL Limited Factor VII Haemophilia B Von Willebrand disease Coagulation
12	Fact Sheet CSL BehringCSL Sales $5.5 Billion CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we develop Add to Reading List Source URL: www.cslbehring.com Language: English - Date: 2016-02-17 12:07:42 Medicine CSL Behring Clinical medicine Microbiology Coagulation system CSL Limited Hereditary angioedema Behring CSL Coagulation Marburg
13	News Releases Global Home \| CSL Behring US \| CSL Plasma \| All CSL Behring Web Sites Add to Reading List Source URL: www.cslbehring.at Language: English - Date: 2013-11-18 05:52:29 Blood Coagulation system Anatomy Haemophilia Peripheral membrane proteins CSL Behring Recombinant proteins CSL Limited Coagulation Factor VII Factor IX Haemophilia C
14	Associazioni di pazienti a cui CSL Behring ha erogato un contributo liberale nel corso del 2015 • • • • Add to Reading List Source URL: www.cslbehring.it Language: Italian - Date: 2016-02-14 05:32:53
15	Life Cycle Management ensures continuous improvement of existing products. Marketplace Add to Reading List Source URL: www.csl.com.au Language: English - Date: 2015-11-25 04:27:21 CSL Behring CSL Limited Haemophilia Corporate social responsibility
16	For immediate release 26 May 2016 AFSTYLA® (rFVIII-Single Chain) – FDA approval CSL Limited (ASX:CSL; USOTC:CSLLY) - CSL today announced that the US Food and Drug Administration (FDA) has approved AFSTYLA® [Antihaemo Add to Reading List Source URL: www.csl.com.au Language: English - Date: 2016-05-25 20:22:52 Haemophilia Coagulation system CSL Behring Recombinant proteins CSL Limited Factor VIII CSL Coagulation
17	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use AFSTYLA safely and effectively. See full prescribing information for AFSTYLA. ----------------------------DOSAGE FOR Add to Reading List Source URL: labeling.cslbehring.com Language: English - Date: 2016-05-26 14:29:43 Blood Medicine Clinical medicine RTT Von Willebrand disease Cryoprecipitate Recombinant factor VIIa CSL Behring Haemophilia International unit Turoctocog alfa
18	The Swiss Arbeitgeber Award 2016 A BENCHMARKING INITIATIVE BASED ON THE LARGEST AND MOST COMPREHENSIVE EMPLOYEE SURVEY IN SWITZERLAND DESIGNED AND MANAGED BY ICOMMIT SUPPORTED BY THE SWISS EMPLOYERS’ FEDERATION (SCHWEI Add to Reading List Source URL: www.hr-swiss-congress.ch Language: English - Date: 2016-01-29 04:45:49 Business Human resource management Workplace Employment Professional studies Working time Evaluation Telecommuting CSL Behring
19	Major Therapeutic Products Marketed by CSL Behring Bleeding Disorders Coagulation therapies are used to treat bleeding disorders such as hemophilia, Von Willebrand Disease and more.  Add to Reading List Source URL: www.cslbehring.com Language: English - Date: 2016-03-15 19:08:23
20	HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use IDELVION® safely and effectively. See full prescribing information for IDELVION. --------------------------------DO Add to Reading List Source URL: labeling.cslbehring.com Language: English - Date: 2016-03-15 15:43:12 Medicine Coagulation system Clinical medicine Health Peripheral membrane proteins Factor IX Zymogens CSL Behring Coagulation Haemophilia Bleeding Disseminated intravascular coagulation

UPDATE